LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 23

Search options

  1. Article ; Online: Common Questions About Streptococcal Pharyngitis.

    Kalra, Monica G / Higgins, Kim E / Perez, Evan D

    American family physician

    2016  Volume 94, Issue 1, Page(s) 24–31

    Abstract: Group A beta-hemolytic streptococcal (GABHS) infection causes 15% to 30% of sore throats in children and 5% to 15% in adults, and is more common in the late winter and early spring. The strongest independent predictors of GABHS pharyngitis are patient ... ...

    Abstract Group A beta-hemolytic streptococcal (GABHS) infection causes 15% to 30% of sore throats in children and 5% to 15% in adults, and is more common in the late winter and early spring. The strongest independent predictors of GABHS pharyngitis are patient age of five to 15 years, absence of cough, tender anterior cervical adenopathy, tonsillar exudates, and fever. To diagnose GABHS pharyngitis, a rapid antigen detection test should be ordered in patients with a modified Centor or FeverPAIN score of 2 or 3. First-line treatment for GABHS pharyngitis includes a 10-day course of penicillin or amoxicillin. Patients allergic to penicillin can be treated with firstgeneration cephalosporins, clindamycin, or macrolide antibiotics. Nonsteroidal anti-inflammatory drugs are more effective than acetaminophen and placebo for treatment of fever and pain associated with GABHS pharyngitis; medicated throat lozenges used every two hours are also effective. Corticosteroids provide only a small reduction in the duration of symptoms and should not be used routinely.
    MeSH term(s) Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Antigens, Bacterial ; Exudates and Transudates ; Fever/etiology ; Humans ; Lymphadenopathy/etiology ; Neck ; Pain Management ; Penicillins/therapeutic use ; Pharyngitis/complications ; Pharyngitis/diagnosis ; Pharyngitis/drug therapy ; Pharyngitis/immunology ; Streptococcal Infections/complications ; Streptococcal Infections/diagnosis ; Streptococcal Infections/drug therapy ; Streptococcal Infections/immunology ; Streptococcus pyogenes
    Chemical Substances Anti-Bacterial Agents ; Anti-Inflammatory Agents, Non-Steroidal ; Antigens, Bacterial ; Penicillins ; Amoxicillin (804826J2HU)
    Language English
    Publishing date 2016-05-10
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 412694-4
    ISSN 1532-0650 ; 0002-838X ; 0572-3612
    ISSN (online) 1532-0650
    ISSN 0002-838X ; 0572-3612
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Prevention of malaria in travelers.

    Johnson, Brett A / Kalra, Monica G

    American family physician

    2012  Volume 85, Issue 10, Page(s) 973–977

    Abstract: There are approximately 300 million cases of malaria each year, resulting in 1 million deaths worldwide. Family physicians often encounter patients preparing to travel to malaria-endemic regions. Physicians should have basic knowledge of parasite ... ...

    Abstract There are approximately 300 million cases of malaria each year, resulting in 1 million deaths worldwide. Family physicians often encounter patients preparing to travel to malaria-endemic regions. Physicians should have basic knowledge of parasite transmission and malaria prevention. The risk of malaria acquisition is based largely on geographic location and travel season. Most cases occur in sub-Saharan Africa, the Indian subcontinent, and Southeast Asia between the months of May and December. Key elements in prevention include barrier protection and chemoprophylaxis. Travelers to malaria-endemic areas should be advised to use mosquito repellent at all times and bed netting at night. Prophylactic medication should be initiated before travel and continued after return. Travelers should be warned that malaria symptoms can present up to one year after a mosquito bite. Symptoms are vague, and may include fever, chills, arthralgias, and headaches. Travelers experiencing symptoms should seek prompt medical attention.
    MeSH term(s) Antimalarials/administration & dosage ; Chemoprevention/methods ; Health Knowledge, Attitudes, Practice ; Humans ; Malaria/drug therapy ; Malaria/prevention & control ; Patient Education as Topic ; Primary Health Care/methods ; Professional-Patient Relations ; Referral and Consultation ; Seasons ; Travel ; Travel Medicine ; Tropical Climate ; United States
    Chemical Substances Antimalarials
    Language English
    Publishing date 2012-05-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 412694-4
    ISSN 1532-0650 ; 0002-838X ; 0572-3612
    ISSN (online) 1532-0650
    ISSN 0002-838X ; 0572-3612
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Intertrigo and secondary skin infections.

    Kalra, Monica G / Higgins, Kim E / Kinney, Bruce S

    American family physician

    2014  Volume 89, Issue 7, Page(s) 569–573

    Abstract: Intertrigo is a superficial inflammatory dermatitis occurring on two closely opposed skin surfaces as a result of moisture, friction, and lack of ventilation. Bodily secretions, including perspiration, urine, and feces, often exacerbate skin inflammation. ...

    Abstract Intertrigo is a superficial inflammatory dermatitis occurring on two closely opposed skin surfaces as a result of moisture, friction, and lack of ventilation. Bodily secretions, including perspiration, urine, and feces, often exacerbate skin inflammation. Physical examination of skin folds reveals regions of erythema with peripheral scaling. Excessive friction and inflammation can cause skin breakdown and create an entry point for secondary fungal and bacterial infections, such as Candida, group A beta-hemolytic streptococcus, and Corynebacterium minutissimum. Candidal intertrigo is commonly diagnosed clinically, based on the characteristic appearance of satellite lesions. Diagnosis may be confirmed using a potassium hydroxide preparation. Resistant cases require oral fluconazole therapy. Bacterial superinfections may be identified with bacterial culture or Wood lamp examination. Fungal lesions are treated with topical nystatin, clotrimazole, ketoconazole, oxiconazole, or econazole. Secondary streptococcal infections are treated with topical mupirocin or oral penicillin. Corynebacterium infections are treated with oral erythromycin.
    MeSH term(s) Anti-Infective Agents/therapeutic use ; Coinfection ; Diagnosis, Differential ; Humans ; Intertrigo/diagnosis ; Intertrigo/drug therapy ; Intertrigo/microbiology ; Skin Diseases, Infectious/complications ; Skin Diseases, Infectious/drug therapy
    Chemical Substances Anti-Infective Agents
    Language English
    Publishing date 2014-04-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 412694-4
    ISSN 1532-0650 ; 0002-838X ; 0572-3612
    ISSN (online) 1532-0650
    ISSN 0002-838X ; 0572-3612
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Suboptimal Chest Radiography and Artificial Intelligence: The Problem and the Solution.

    Dasegowda, Giridhar / Kalra, Mannudeep K / Abi-Ghanem, Alain S / Arru, Chiara D / Bernardo, Monica / Saba, Luca / Segota, Doris / Tabrizi, Zhale / Viswamitra, Sanjaya / Kaviani, Parisa / Karout, Lina / Dreyer, Keith J

    Diagnostics (Basel, Switzerland)

    2023  Volume 13, Issue 3

    Abstract: Chest radiographs (CXR) are the most performed imaging tests and rank high among the radiographic exams with suboptimal quality and high rejection rates. Suboptimal CXRs can cause delays in patient care and pitfalls in radiographic interpretation, given ... ...

    Abstract Chest radiographs (CXR) are the most performed imaging tests and rank high among the radiographic exams with suboptimal quality and high rejection rates. Suboptimal CXRs can cause delays in patient care and pitfalls in radiographic interpretation, given their ubiquitous use in the diagnosis and management of acute and chronic ailments. Suboptimal CXRs can also compound and lead to high inter-radiologist variations in CXR interpretation. While advances in radiography with transitions to computerized and digital radiography have reduced the prevalence of suboptimal exams, the problem persists. Advances in machine learning and artificial intelligence (AI), particularly in the radiographic acquisition, triage, and interpretation of CXRs, could offer a plausible solution for suboptimal CXRs. We review the literature on suboptimal CXRs and the potential use of AI to help reduce the prevalence of suboptimal CXRs.
    Language English
    Publishing date 2023-01-23
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662336-5
    ISSN 2075-4418
    ISSN 2075-4418
    DOI 10.3390/diagnostics13030412
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A case of heterotopic heart transplant as a "biologic left ventricular assist" in restrictive cardiomyopathy.

    Copeland, Hannah / Kalra, Nishant / Gustafson, Monica / Coehlo-Anderson, Romana / Friedman, Mark / Copeland, Jack G

    World journal for pediatric & congenital heart surgery

    2011  Volume 2, Issue 4, Page(s) 637–640

    Abstract: Heterotopic heart transplant (HHT) has traditionally been thought of as creating 2 parallel circulations. We present a case of using the donor heart as a "biologic left ventricular assist" (bio-LVA). The heterotopic technique used consisted of 4 ... ...

    Abstract Heterotopic heart transplant (HHT) has traditionally been thought of as creating 2 parallel circulations. We present a case of using the donor heart as a "biologic left ventricular assist" (bio-LVA). The heterotopic technique used consisted of 4 anastomoses: the donor heart pulmonary artery (PA) to the native heart right atrium, the superior vena cava to superior vena cava, the left atrium to left atrium, and the aorta to aorta. A 9-year-old boy with restrictive cardiomyopathy, a PA pressure of 85/53 mmHg, received a HHT because he would probably not be able to tolerate an orthotopic heart transplant secondary to elevated PA pressure. He is currently alive 14 years post-transplantation.
    Language English
    Publishing date 2011-10-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2550261-X
    ISSN 2150-136X ; 2150-1351
    ISSN (online) 2150-136X
    ISSN 2150-1351
    DOI 10.1177/2150135111411588
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Glomerular inflammation correlates with endothelial injury and with IL-6 and IL-1β secretion in the peripheral blood.

    Batal, Ibrahim / De Serres, Sacha A / Mfarrej, Bechara G / Grafals, Monica / Pinkus, Geraldine S / Kalra, Aarti / Weins, Astrid / Bijol, Vanesa / Rennke, Helmut G / Guleria, Indira / Abdi, Reza / Chandraker, Anil / Najafian, Nader

    Transplantation

    2014  Volume 97, Issue 10, Page(s) 1034–1042

    Abstract: Background: Transplant glomerulitis is an active form of glomerular injury associated with suboptimal graft outcome, inadequate histologic reproducibility, and poorly understood pathogenesis. Using a modified pathologic schema where glomerular ... ...

    Abstract Background: Transplant glomerulitis is an active form of glomerular injury associated with suboptimal graft outcome, inadequate histologic reproducibility, and poorly understood pathogenesis. Using a modified pathologic schema where glomerular inflammation is defined by the presence of five or more leukocytes per glomerulus, we sought to assess the reproducibility of transplant glomerulitis and to prospectively investigate the pathogenesis of glomerular inflammation.
    Methods: Our cohort includes 59 kidney transplant recipients who underwent 60 "for cause" allograft biopsies. In addition to light microscopy, the majority of the biopsies were assessed using immunohistochemistry, immunofluorescence, and electron microscopy studies. Biopsies were classified as noninflamed (n=21), inflamed (borderline changes or above) without glomerulitis (n=21), and transplant glomerulitis (n=18). Peripheral blood was collected on the day of biopsy and cytokines secreted by peripheral blood mononuclear cells (PBMCs) were measured ex vivo.
    Results: Our modified schema had higher inter-observer agreement for detecting glomerulitis than that of the current Banff schema. Biopsies with glomerulitis showed ultrastructural signs of glomerular capillary wall remodeling. In contrast to other anatomic compartments, intraglomerular leukocytes in glomerulitis group consisted largely of monocytes. Patients with glomerulitis had high levels of IL-6 and IL-1β secreted by PBMCs. Furthermore, the percentage of inflamed glomeruli and the number of intraglomerular monocytes showed independent association with IL-6 and IL-1β levels, which tended to correlate with subsequent estimated glomerular filtration rate decline.
    Conclusions: Inter-observer reproducibility of transplant glomerulitis can be improved by using more stringent histologic criteria. Glomerular inflammation correlates with endothelial injury, monocyte influx, and IL-6 and IL-β secretion by circulating immune cells.
    MeSH term(s) Adult ; Aged ; Biomarkers/blood ; Biopsy ; Disease Progression ; Endothelium, Vascular/metabolism ; Endothelium, Vascular/physiopathology ; Endothelium, Vascular/ultrastructure ; Female ; Follow-Up Studies ; Glomerulonephritis/blood ; Glomerulonephritis/etiology ; Glomerulonephritis/physiopathology ; Graft Rejection/blood ; Graft Rejection/complications ; Graft Rejection/physiopathology ; Humans ; Immunohistochemistry ; Interleukin-1beta/blood ; Interleukin-1beta/secretion ; Interleukin-6/blood ; Interleukin-6/secretion ; Kidney Glomerulus/blood supply ; Kidney Glomerulus/ultrastructure ; Kidney Transplantation ; Male ; Microscopy, Electron ; Middle Aged ; Monocytes/secretion ; Prospective Studies ; ROC Curve ; Reproducibility of Results
    Chemical Substances Biomarkers ; Interleukin-1beta ; Interleukin-6
    Language English
    Publishing date 2014-05-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 208424-7
    ISSN 1534-6080 ; 0041-1337
    ISSN (online) 1534-6080
    ISSN 0041-1337
    DOI 10.1097/01.TP.0000441096.22471.36
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

    Kiryluk, Krzysztof / Sanchez-Rodriguez, Elena / Zhou, Xu-Jie / Zanoni, Francesca / Liu, Lili / Mladkova, Nikol / Khan, Atlas / Marasa, Maddalena / Zhang, Jun Y / Balderes, Olivia / Sanna-Cherchi, Simone / Bomback, Andrew S / Canetta, Pietro A / Appel, Gerald B / Radhakrishnan, Jai / Trimarchi, Hernan / Sprangers, Ben / Cattran, Daniel C / Reich, Heather /
    Pei, York / Ravani, Pietro / Galesic, Kresimir / Maixnerova, Dita / Tesar, Vladimir / Stengel, Benedicte / Metzger, Marie / Canaud, Guillaume / Maillard, Nicolas / Berthoux, Francois / Berthelot, Laureline / Pillebout, Evangeline / Monteiro, Renato / Nelson, Raoul / Wyatt, Robert J / Smoyer, William / Mahan, John / Samhar, Al-Akash / Hidalgo, Guillermo / Quiroga, Alejandro / Weng, Patricia / Sreedharan, Raji / Selewski, David / Davis, Keefe / Kallash, Mahmoud / Vasylyeva, Tetyana L / Rheault, Michelle / Chishti, Aftab / Ranch, Daniel / Wenderfer, Scott E / Samsonov, Dmitry / Claes, Donna J / Akchurin, Oleh / Goumenos, Dimitrios / Stangou, Maria / Nagy, Judit / Kovacs, Tibor / Fiaccadori, Enrico / Amoroso, Antonio / Barlassina, Cristina / Cusi, Daniele / Del Vecchio, Lucia / Battaglia, Giovanni Giorgio / Bodria, Monica / Boer, Emanuela / Bono, Luisa / Boscutti, Giuliano / Caridi, Gianluca / Lugani, Francesca / Ghiggeri, GianMarco / Coppo, Rosanna / Peruzzi, Licia / Esposito, Vittoria / Esposito, Ciro / Feriozzi, Sandro / Polci, Rosaria / Frasca, Giovanni / Galliani, Marco / Garozzo, Maurizio / Mitrotti, Adele / Gesualdo, Loreto / Granata, Simona / Zaza, Gianluigi / Londrino, Francesco / Magistroni, Riccardo / Pisani, Isabella / Magnano, Andrea / Marcantoni, Carmelita / Messa, Piergiorgio / Mignani, Renzo / Pani, Antonello / Ponticelli, Claudio / Roccatello, Dario / Salvadori, Maurizio / Salvi, Erica / Santoro, Domenico / Gembillo, Guido / Savoldi, Silvana / Spotti, Donatella / Zamboli, Pasquale / Izzi, Claudia / Alberici, Federico / Delbarba, Elisa / Florczak, Michał / Krata, Natalia / Mucha, Krzysztof / Pączek, Leszek / Niemczyk, Stanisław / Moszczuk, Barbara / Pańczyk-Tomaszewska, Malgorzata / Mizerska-Wasiak, Malgorzata / Perkowska-Ptasińska, Agnieszka / Bączkowska, Teresa / Durlik, Magdalena / Pawlaczyk, Krzysztof / Sikora, Przemyslaw / Zaniew, Marcin / Kaminska, Dorota / Krajewska, Magdalena / Kuzmiuk-Glembin, Izabella / Heleniak, Zbigniew / Bullo-Piontecka, Barbara / Liberek, Tomasz / Dębska-Slizien, Alicja / Hryszko, Tomasz / Materna-Kiryluk, Anna / Miklaszewska, Monika / Szczepańska, Maria / Dyga, Katarzyna / Machura, Edyta / Siniewicz-Luzeńczyk, Katarzyna / Pawlak-Bratkowska, Monika / Tkaczyk, Marcin / Runowski, Dariusz / Kwella, Norbert / Drożdż, Dorota / Habura, Ireneusz / Kronenberg, Florian / Prikhodina, Larisa / van Heel, David / Fontaine, Bertrand / Cotsapas, Chris / Wijmenga, Cisca / Franke, Andre / Annese, Vito / Gregersen, Peter K / Parameswaran, Sreeja / Weirauch, Matthew / Kottyan, Leah / Harley, John B / Suzuki, Hitoshi / Narita, Ichiei / Goto, Shin / Lee, Hajeong / Kim, Dong Ki / Kim, Yon Su / Park, Jin-Ho / Cho, BeLong / Choi, Murim / Van Wijk, Ans / Huerta, Ana / Ars, Elisabet / Ballarin, Jose / Lundberg, Sigrid / Vogt, Bruno / Mani, Laila-Yasmin / Caliskan, Yasar / Barratt, Jonathan / Abeygunaratne, Thilini / Kalra, Philip A / Gale, Daniel P / Panzer, Ulf / Rauen, Thomas / Floege, Jürgen / Schlosser, Pascal / Ekici, Arif B / Eckardt, Kai-Uwe / Chen, Nan / Xie, Jingyuan / Lifton, Richard P / Loos, Ruth J F / Kenny, Eimear E / Ionita-Laza, Iuliana / Köttgen, Anna / Julian, Bruce A / Novak, Jan / Scolari, Francesco / Zhang, Hong / Gharavi, Ali G

    Nature genetics

    2023  Volume 55, Issue 7, Page(s) 1091–1105

    Abstract: IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751 controls across 17 international cohorts. We ...

    Abstract IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751 controls across 17 international cohorts. We defined 30 genome-wide significant risk loci explaining 11% of disease risk. A total of 16 loci were new, including TNFSF4/TNFSF18, REL, CD28, PF4V1, LY86, LYN, ANXA3, TNFSF8/TNFSF15, REEP3, ZMIZ1, OVOL1/RELA, ETS1, IGH, IRF8, TNFRSF13B and FCAR. The risk loci were enriched in gene orthologs causing abnormal IgA levels when genetically manipulated in mice. We also observed a positive genetic correlation between IgAN and serum IgA levels. High polygenic score for IgAN was associated with earlier onset of kidney failure. In a comprehensive functional annotation analysis of candidate causal genes, we observed convergence of biological candidates on a common set of inflammatory signaling pathways and cytokine ligand-receptor pairs, prioritizing potential new drug targets.
    MeSH term(s) Animals ; Mice ; Glomerulonephritis, IGA/drug therapy ; Glomerulonephritis, IGA/genetics ; Glomerulonephritis, IGA/diagnosis ; Genome-Wide Association Study ; Immunoglobulin A/genetics
    Chemical Substances Immunoglobulin A
    Language English
    Publishing date 2023-06-19
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108734-1
    ISSN 1546-1718 ; 1061-4036
    ISSN (online) 1546-1718
    ISSN 1061-4036
    DOI 10.1038/s41588-023-01422-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance.

    Harinstein, Lisa / Kalra, Dipti / Kortepeter, Cindy M / Muñoz, Monica A / Wu, Eileen / Dal Pan, Gerald J

    Drug safety

    2018  Volume 42, Issue 5, Page(s) 649–655

    Abstract: ... information in the narrative (e.g., temporality, comorbidities).: Results: Compared with non-industry ...

    Abstract Introduction and objective: Adverse event reports from industry-sponsored programs, such as patient support programs, have contributed to a rise in the number of individual case safety reports in the US Food and Drug Administration Adverse Event Reporting System database. This study aimed to characterize individual case safety reports from industry-sponsored program and non-industry-sponsored program sources and compare their usefulness in safety signal detection.
    Methods: Individual case safety reports of six drug and biological products were identified in the Food and Drug Administration Adverse Event Reporting System database between the date of Food and Drug Administration product approval and the first quarter of 2017. A random subset of industry-sponsored program and non-industry-sponsored program individual case safety reports were then compared to identify differences in reporters, outcomes, data completeness, and usefulness. The 'usefulness' of individual case safety reports was assessed by manually reviewing the availability of key information in the narrative (e.g., temporality, comorbidities).
    Results: Compared with non-industry-sponsored program reports, more industry-sponsored program reports were associated with a serious outcome (51.4% vs. 58.8%, p = 0.02) and were reported by consumers (35.5% vs. 50.4%, p < 0.01). Industry-sponsored program reports tended to contain more data elements than non-industry-sponsored program reports (i.e., age, sex, indication for use), but completeness was variable across products. No significant difference in usefulness was identified between non-industry-sponsored program and industry-sponsored program individual case safety reports (30.6% vs. 28.5%, p = 0.42). Useful reports that contained at least one serious, unlabeled adverse event represented only 4% and 6.2% of the non-industry-sponsored program and industry-sponsored program report cohorts, respectively.
    Conclusions: Our study suggests that reports obtained from industry-sponsored programs in the Food and Drug Administration Adverse Event Reporting System database contain more data elements but are similar to non-industry-sponsored program reports with regard to 'usefulness' in signal detection.
    MeSH term(s) Adverse Drug Reaction Reporting Systems/standards ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Biological Products/adverse effects ; Biological Products/therapeutic use ; Cardiovascular Agents/adverse effects ; Cardiovascular Agents/therapeutic use ; Drug Industry ; Hematologic Agents/adverse effects ; Hematologic Agents/therapeutic use ; Humans ; Product Surveillance, Postmarketing/standards
    Chemical Substances Antineoplastic Agents ; Biological Products ; Cardiovascular Agents ; Hematologic Agents
    Language English
    Publishing date 2018-12-19
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 1018059-x
    ISSN 1179-1942 ; 0114-5916
    ISSN (online) 1179-1942
    ISSN 0114-5916
    DOI 10.1007/s40264-018-0759-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Antifungal efficacy of three medicinal plants

    Sharma, Hunny / Yunus, G Y / Agrawal, Rohit / Kalra, Monika / Verma, Swati / Bhattar, Supriya

    Indian journal of dental research : official publication of Indian Society for Dental Research

    2016  Volume 27, Issue 4, Page(s) 433–436

    Abstract: ... antifungal agents.: Materials and methods: Bark of G. glabra, stem of F. religiosa, and husk of P. major were ... were applied for statistical analysis.: Results: G. glabra was found to be most effective ... of F. religiosa and P. major with itraconazole 10 mcg.: Conclusion: G. glabra, F. religiosa, and P ...

    Abstract Introduction: From ancient times, plants with medicinal values are being tested and used in the treatment of various infectious diseases.
    Aims and objectives: The present in vitro study was designed to assess the antifungal activity of three commonly available medicinal plants Glycyrrhiza glabra, Ficus religiosa, and Plantago major on inhibiting oral Candida albicans in comparison to standard antifungal agents.
    Materials and methods: Bark of G. glabra, stem of F. religiosa, and husk of P. major were collected, crushed into fine powder, and dissolved in 67% ethanol. Extracts were subjected to antifungal efficacy test against oral C. albicans (ATCC 66027) using Kirby-Bauer disc diffusion method. Mean zone of inhibition (ZOI) was measured by HI antibiotic zone scale. One-way ANOVA using Tukey's post hoc and t-test were applied for statistical analysis.
    Results: G. glabra was found to be most effective among the three with highest mean ZOI measuring 19.8 ± 0.83, 19.4 ± 0.54, and 18.2 ± 1.09 at 24, 48, and 72 h, respectively. Tukey's post hoc test showed statistically nonsignificant difference between antifungal activity of F. religiosa and P. major with itraconazole 10 mcg.
    Conclusion: G. glabra, F. religiosa, and P. major showed acceptable potency against C. albicans (ATCC 66027) comparable to that of synthetic antifungal agents. However, further studies should be undertaken to affirm the same and test their efficacy in different concentrations and clinical utility.
    MeSH term(s) Antifungal Agents/pharmacology ; Candida albicans/drug effects ; Ficus ; Glycyrrhiza ; In Vitro Techniques ; Microbial Sensitivity Tests ; Plant Extracts/pharmacology ; Plantago
    Chemical Substances Antifungal Agents ; Plant Extracts
    Language English
    Publishing date 2016-07
    Publishing country India
    Document type Comparative Study ; Journal Article
    ZDB-ID 1354886-4
    ISSN 1998-3603 ; 0970-9290
    ISSN (online) 1998-3603
    ISSN 0970-9290
    DOI 10.4103/0970-9290.191895
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Curability and transferability of atopy with allogeneic hematopoietic cell transplantation.

    Whiteside, Sarah / Chin, Alex / Tripathi, Gaurav / Dharmani-Khan, Poonam / Markova, Marketa / Keslova, Petra / Sedlacek, Petr / Geddes, Michelle N / Lewis, Victor / Modi, Monica / Kalra, Amit / Dabas, Rosy / Akhter, Ariz / Larratt, Loree / van Slyke, Tiffany / Brandwein, Joseph / Spellman, Stephen R / Leigh, Richard / Daly, Andrew /
    Khan, Faisal M / Storek, Jan

    Bone marrow transplantation

    2020  Volume 55, Issue 7, Page(s) 1282–1289

    Abstract: Atopy is excessive production of IgE in response to allergens. We evaluated in patients undergoing allogeneic hematopoietic cell transplantation (HCT) the following hypotheses: (1) Atopy is "curable" in atopic patients receiving HCT from a nonatopic ... ...

    Abstract Atopy is excessive production of IgE in response to allergens. We evaluated in patients undergoing allogeneic hematopoietic cell transplantation (HCT) the following hypotheses: (1) Atopy is "curable" in atopic patients receiving HCT from a nonatopic donor (D-R+), and (2) Atopy is transferable from atopic donors to nonatopic recipients (D+R-). Atopic patients with atopic donors (D+R+) and non-atopic patients with non-atopic donors (D-R-) served as controls. We measured levels of multiallergen-specific IgE (A-IgE, atopy defined as ≥0.35 kU
    MeSH term(s) Allergens ; Hematopoietic Stem Cell Transplantation ; Humans ; Hypersensitivity, Immediate ; Immunoglobulin E
    Chemical Substances Allergens ; Immunoglobulin E (37341-29-0)
    Language English
    Publishing date 2020-03-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632854-4
    ISSN 1476-5365 ; 0268-3369 ; 0951-3078
    ISSN (online) 1476-5365
    ISSN 0268-3369 ; 0951-3078
    DOI 10.1038/s41409-020-0876-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top